Show simple item record

Opioid receptor subtype-specific cross-tolerance to the effects of morphine on schedule-controlled behavior in mice

dc.contributor.authorSolomon, Robert E.en_US
dc.contributor.authorGoodrich, James E.en_US
dc.contributor.authorKatz, Jonathan L.en_US
dc.date.accessioned2006-09-11T17:47:39Z
dc.date.available2006-09-11T17:47:39Z
dc.date.issued1988-10en_US
dc.identifier.citationSolomon, Robert E.; Goodrich, James E.; Katz, Jonathan L.; (1988). "Opioid receptor subtype-specific cross-tolerance to the effects of morphine on schedule-controlled behavior in mice." Psychopharmacology 96(2): 218-222. <http://hdl.handle.net/2027.42/46448>en_US
dc.identifier.issn0033-3158en_US
dc.identifier.issn1432-2072en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/46448
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=2852820&dopt=citationen_US
dc.description.abstractKey-press responding of mice was maintained under a fixed-ratio (FR) 30-response schedule of food presentation. Successive 3-min periods during which the experimental chamber was illuminated and the schedule was in effect were preceded by 10-min time-out (TO) periods during which all lights were out and responses had no scheduled consequences. Intraperitoneal (IP) injections of saline or of cumulative doses of drugs were given at the start of each TO period. Successive saline injections had little or no effect on response rates, whereas the μ-opioid agonists morphine (0.1–10.0 mg/kg) and levorphanol (0.1–3.0 mg/kg), the κ-opioid agonist ethylketazocine (0.03–3.0 mg/kg), the mixed μ-/δ-opioid agonist metkephamid (0.1–10.0 mg/kg), and the nonopioid dissociative anesthetic ketamine (1.0–100.0 mg/kg) generally produced dose-related decreases in response rates. Following chronic administration of morphine (100.0 mg/kg/6 h), tolerance developed to the effects of morphine on rates of responding. In addition, a comparable degree of cross-tolerance developed to the effects of levorphanol and metkephamid. On the other hand, there was no evidence of cross-tolerance to the effects of ethylketazocine or ketamine. These results are consistent with the evidence suggesting that different opioid agonists exert their behavioral effects through distinct classes of opioid receptors.en_US
dc.format.extent498821 bytes
dc.format.extent3115 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherSpringer-Verlag; Springer-Verlag Berlin Heidelbergen_US
dc.subject.otherLevorphanolen_US
dc.subject.otherEthylketazocineen_US
dc.subject.otherMorphineen_US
dc.subject.otherSchedule-controlled Behavioren_US
dc.subject.otherBiomedicineen_US
dc.subject.otherPharmacology/Toxicologyen_US
dc.subject.otherPsychiatryen_US
dc.subject.otherMiceen_US
dc.subject.otherToleranceen_US
dc.subject.otherKetamineen_US
dc.subject.otherMetkephamiden_US
dc.subject.otherCross-toleranceen_US
dc.titleOpioid receptor subtype-specific cross-tolerance to the effects of morphine on schedule-controlled behavior in miceen_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelPsychiatryen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelChemistryen_US
dc.subject.hlbsecondlevelBiological Chemistryen_US
dc.subject.hlbtoplevelScienceen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan Medical School, 48109, Ann Arbor, MI, USA; Department of Pharmacology, University of Iowa College of Medicine, 52242, Iowa City, IA, USAen_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan Medical School, 48109, Ann Arbor, MI, USA; CNS Drug Discovery Program, Warner-Lambert/Parke-Davis Pharmaceutical Research Division, 48105, Ann Arbor, MI, USAen_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan Medical School, 48109, Ann Arbor, MI, USA; National Institute on Drug Abuse, Addiction Research Center, P.O. Box 5180, 21224, Baltimore, MD, USAen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.identifier.pmid2852820en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/46448/1/213_2004_Article_BF00177563.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1007/BF00177563en_US
dc.identifier.sourcePsychopharmacologyen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.